The subject of the order is the delivery of medicinal product and pharmaceutical raw material used in the framework of the EMPATia non-commercial clinical trial — 2 packages, on the basis set out in the proposed provisions of the contract in quantities resulting from current needs and within the deadlines resulting from from the contract entered into.
Package No 1 — EmpagliflozinumEmpagliflozinum 10 mg film-coated tablets, Licence No EU/1/14/930/014.
Package 2 — Lactose monohydrateLactose monohydrate, pack 100 g, licence no 13859.